Microbiology and infective

Acar J., M. Casewell, J. Freeman, H. Goossens, and C. Friis (2000). Avoparcin and virginia-mycin as animal growth promoters A plea for science in decision making. Clinical Microbiology and Infections 6 477-482. 

Kiimmeier K. and A. Henninger (2004). Promoting resistance by the emission of antibiotics from households into effluent. Clinical Microbiology and Infection 9 1203-1214. 

Gillespie S and Bamford K (2003) Medical Microbiology and Infection at a Glance, 2nd edn. Oxford Blackwells. 

Woodford, N. (2005) Biological counterstrike antibiotic resistance mechanisms of Gram-positive cocci. Clinical Microbiology and Infection,... 

S WILES, K FERGUSON, B ROBERTSON, D YOUNG Centre for Molecular Microbiology and Infection, Imperial College London, SW7 2AZ, UK Email siouxsie.wiles imperial.ac.uk... 

The Jordan Report 2000, Accelerated Development of Vaccines, Division of Microbiology and Infections Diseases, National Institutes of Health. Washington DC, http //www.niaid.nih.gov/publications/pdf/ jordan.pdf... 

Fig. 3.11. 2D-GE of proteins from the soilhiictehum Burkholderia cepacia. The separation in the first dimension (left to right) was achieved by IFF. In the second dimension, the proteins were separated according to their molecular weight in a polyacrylamide gel with a pore size gradient (Courtesy of B. Crossett, Centre for Molecular Microbiology and Infection, Imperial College London, UK.)...

Ando, H., Mitarai, S., Kondo, Y., Suetake, T., Sekiguchi, J.-I., Kato, S., et al., 2010. Pyrazinamide resistance in multidrug-resistant mycobacterium tuberculosis isolates in Japan. Clinical Microbiology and Infection The Official Publication of the European... 

Mackay, I. M. (2004). Real-time PCR in the microbiology laboratory. Clinical Microbiology and Infection, 10(3), 190-212. 

The penicillins are a class of compound having the general structure (1). Because of their unique effectiveness in the treatment of bacterial infections in humans, these compounds have been investigated intensively from the chemical, microbiological and clinical points of view since about 1940. The early history of these developments (see especially B-80MI51100, B-49MI51100) contains the following pivotal studies ... 

Sethi S, Murphy TF. Acute exacerbations of chronic bronchitis new developments concerning microbiology and pathophysiology— impact on approaches to risk stratification and therapy. Infect Dis Clin North Am 2004 18 861-882. 

Minson, A. C., Alphaherpesviruses herpes simplex and varicella zoster virus infection, In Topley and Wilson s Microbiology And Microbial Infections, 9th edn. Mahy, B. Collier, L., Eds. Arnold, London, 1998, Vol. 1, 325 339... 

Jones R.N. and DJ. Biedenbach (2003). Comparative activity of geienoxacin (BMS 284756), a novel desfluoioquinolone tested against 8,331 isolates from community-acquired respiratory tract infections North American results from the SENTRY Antirrricrobial SrrrveiUance Program (1999-2001). Diagnostic Microbiology and Infectious Disease 45 273-278. 

The modified ITT, where unqualified patients are excluded, and patients with clinically and or microbiologically documented infections (as stated in the protocol), who have received at least one dose of the investigated drug thus addressed, is particularly valid for regulatory purposes. ... 

Nightingale CH. Moxifloxacin, a new antibiotic designed to treat community-acquired respiratory tract infections a review of microbiologic and pharmacokinetic-pharmacodynamic characteristics. Pharmacotherapy, 2000, 20,... 

Steidler, L. (2001), Microbiological and immunological strategies for treatment of inflammatory bowel disease, Microbes Infect., 3,1157-1166. 

If P. aeruginosa is suspected, or with sepsis from hospital-acquired infections, an antipseudomonal antibiotic, such as ceftazidime, is recommended. The antimicrobial regimen should be reassessed after 48 to 72 hours based on microbiological and clinical data. 

Sigler L Agents of adiaspiromycosis in Ajello L, Hay R (eds) Topley and Wilson s Microbiology and Microbial Infections, 9 ed. London, Arnold, 1998, pp 571—583. 

Jacobs, W.R. Snapper, S.B. Lugosi, L. Bloom, L. Bloom, B.R. Development of BCG as a recombinant vaccine vehicle. In T-Cell Paradigms in Parasitic and Bacterial Infections. Current Topics in Microbiology and Immunology, Kaufmann, S.H.E., Ed. Springer-Verlag Berlin, 1990 155, 153-160. 

Denyer, S. Baird, R. (1990) Guide to Microbiological Control in Pharmaceuticals. Ellis Horwood, Chichester. Gardner, J. F. Peel, M. M. (1998) Sterilization, Disinfection and Infection Control, 3rd edn. Churchill Livingstone, Melbourne. 

---